These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17465232)
21. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis. Zhang H; Sun XF; Synnerstad I; Rosdahl I Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757 [TBL] [Abstract][Full Text] [Related]
22. Expression of Fas and FasL in human serous ovarian epithelial tumors. van Haaften-Day C; Russell P; Davies S; King NJ; Tattersall MH Hum Pathol; 2003 Jan; 34(1):74-9. PubMed ID: 12605369 [TBL] [Abstract][Full Text] [Related]
23. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Zhang W; Li C; Wang J; He C Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365 [TBL] [Abstract][Full Text] [Related]
24. Epithelial ovarian cancer cells secrete functional Fas ligand. Abrahams VM; Straszewski SL; Kamsteeg M; Hanczaruk B; Schwartz PE; Rutherford TJ; Mor G Cancer Res; 2003 Sep; 63(17):5573-81. PubMed ID: 14500397 [TBL] [Abstract][Full Text] [Related]
25. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients. Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851 [TBL] [Abstract][Full Text] [Related]
27. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer]. Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection. Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484 [TBL] [Abstract][Full Text] [Related]
29. Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors. Arts HJ; de Jong S; Hollema H; Ten Hoor KA; de Vries EG; van der Zee AG Int J Oncol; 2005 Feb; 26(2):379-84. PubMed ID: 15645122 [TBL] [Abstract][Full Text] [Related]
30. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population. Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214 [TBL] [Abstract][Full Text] [Related]
31. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis]. Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887 [TBL] [Abstract][Full Text] [Related]
32. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541 [TBL] [Abstract][Full Text] [Related]
33. Detection of Fas ligand in the bovine oviduct. Bergqvist AS; Killian G; Erikson D; Hoshino Y; Båge R; Sato E; Rodríguez-Martínez H Anim Reprod Sci; 2005 Mar; 86(1-2):71-88. PubMed ID: 15721660 [TBL] [Abstract][Full Text] [Related]
34. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia. Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376 [TBL] [Abstract][Full Text] [Related]
36. Association of functional polymorphisms in FAS and FAS Ligand genes promoter with pre-eclampsia. Salimi S; Moudi B; Farajian Mashhadi F; Tavilani H; Hashemi M; Zand H; Yaghmaei M J Obstet Gynaecol Res; 2014 May; 40(5):1167-73. PubMed ID: 24690069 [TBL] [Abstract][Full Text] [Related]
37. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354 [TBL] [Abstract][Full Text] [Related]
38. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances. Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086 [TBL] [Abstract][Full Text] [Related]
39. Association between FAS and FASL genetic variants and risk of primary brain tumor. Dalan AB; Timirci-Kahraman O; Turan S; Kafadar AM; Yaylim I; Ergen A; Gormus U; Gulec-Yilmaz S; Kaspar C; Isbir T Int J Neurosci; 2014 Jun; 124(6):443-9. PubMed ID: 24094130 [TBL] [Abstract][Full Text] [Related]
40. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer. Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]